JAZZ Stock Jazz Pharmaceuticals (JAZZ, $105.93) was a top loser this week, declining -8.78%

GET DAILY SIGNALS

Get AI intraday signals

JAZZ - Jazz Pharmaceuticals plc

Loading...

Price: $105.93

Daily change: -$7.27 (-6.42%)

Daily volume: 2.6M

Weekly price change: -$10.19 (-8.78%)

Capitalization: $6.4B

Industry: Biotechnology

Jazz Pharmaceuticals (JAZZ, $105.93) was a top weekly loser, falling to $105.93 per share. Of the 804 stocks analyzed in the Biotechnology Industry throughout the week of July 30 - August 6, of them (4) exhibited an Uptrend while of them (5) were in a Downtrend.

JAZZ in downward trend: price may decline as a result of having broken its higher Bollinger Band on November 17, 2025

JAZZ broke above its upper Bollinger Band on November 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 37 similar instances where the stock broke above the upper band. In of the 37 cases the stock fell afterwards. This puts the odds of success at .

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JAZZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 12, 2025. You may want to consider a long position or call options on JAZZ as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for JAZZ just turned positive on November 14, 2025. Looking at past instances where JAZZ's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

JAZZ moved above its 50-day moving average on November 11, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where JAZZ advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JAZZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.697) is normal, around the industry mean (27.115). P/E Ratio (15.380) is within average values for comparable stocks, (51.613). JAZZ's Projected Growth (PEG Ratio) (7.612) is very high in comparison to the industry average of (2.036). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (2.582) is also within normal values, averaging (317.729).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JAZZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.